SUSAN BOYD: Open Payments
NPI 1164431516 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 8 payments from 6 companies in 2025. Trend: 2023 $411 · 2024 $656 · 2025 $433
Food & beverage: $361Education: $71
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $182 |
| Janssen Pharmaceuticals, Inc | 1 | $126 |
| Supernus Pharmaceuticals, Inc. | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| ABBVIE INC. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: SPRAVATO, Qelbree, FANAPT, VRAYLAR, COBENFY.
Industry payments across MD — which companies pay providers there.
